According to Forbes, and numerous other sites, Roivant Sciences is a biotechnology firm Ramaswamy started. His work in connection with COVID-19 places him on an equally questionable level as the Soros ties, even if they are not Soros-financed.
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
Monoclonal antibody
Various monoclonal antibody has been explored in the treatment of COVID-19. Mainly, gimsilumab and leronlimab have been used in the treatment of COVID-19. Gimsilumab targets a pro-inflammatory cytokine known as a granulocyte-macrophage colony-stimulating factor (GM-CSF). The expression of pro-inflammatory cytokines was inhibited by gimsilumab, which increases inflammation. By this mechanism, it reduces the cytokine storm in the airway pathways and provides symptomatic relief to patients from COVID-19
Monoclonal antibody was my plan if I got very sick with covid, which, fortunately, I did not.